Search - tctmd.com

Displaying 641 - 660 of 723

Sort: Relevancy | Date

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Conference News AHA 2016

Incomplete Revascularization Linked With Increased MACE in Subsequent Noncardiac Surgery

Michael O'Riordan

November 15, 2016

News Conference News AHA 2016

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Michael O'Riordan

November 14, 2016

Presentation Cardiovascular Interventions 2016

Precision PCI

Presenter: Richard Shlofmitz

November 11, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

Presentation Cardiovascular Interventions 2016

PCI for STEMI: Fix the Culprit Lesion, or Fix All of the Lesions

Presenter: James Hermiller

November 08, 2016

News Conference News TCT 2016

TRANSFORM-OCT: 生物可吸收和耐久聚合物 DES 早期和晚期愈合率类似

Michael O'Riordan

November 02, 2016

News Conference News TCT 2016

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

Michael O'Riordan

November 02, 2016

News Conference News TCT 2016

TRANSFORM-OCT: Similar Curación Precoz y Tardía con SLF Bioreabsorbibles y de Polímero Duradero

Michael O'Riordan

November 02, 2016

News Conference News TCT 2016

硬 CTO 斑块的新软化方法可以降低手术难度

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2016

Un Nuevo Método para Ablandar la Placa Dura de OTC podría Facilitar las Dificultades de la Intervención

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2016

Novel Method of Softening Hard CTO Plaque May Ease Procedural Difficulties

Yael L. Maxwell

November 02, 2016

News Conference News TCT 2016

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

No-Contrast PCI: A Strategy Based on Intravascular Imaging and Physiology to Avoid Contrast-Induced Nephropathy

Presenter: Adrian P. Banning, Ryan D. Madder, Ziad A. Ali

November 01, 2016

Presentation TCT 2016

Highlights (and my Interpretations) From: ILUMIEN III: OPTIMIZE PCI and COLOR

Presenter: Giulio Guagliumi, Ik-Kyung Jang, Ron Waksman

November 01, 2016

News Industry News TCT 2016

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

November 01, 2016

News Conference News TCT 2016

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

Should the Sequence Be: FFR-PCI-OCT? FFR-PCI-IVUS? Just FFR or just IVUS/OCT? And When Is Angiography Enough?

Presenter: Ik-Kyung Jang, Matthew J. Price, Seung-Jung Park

October 31, 2016

Presentation TCT 2016

Imaging Evaluation During PCI: Prediagnostic Value and Post Optimization

Presenter: Seung-Jung Park, Alan C. Yeung, Akiko Maehara

October 31, 2016

Presentation TCT 2016

Outcome-Derived FFR Threshold for Revascularization: Data From the IRIS FFR Registry (N=7,013)

Presenter: Seung-Jung Park, Alan C. Yeung, Jung-Min Ahn

October 31, 2016

Advertisement

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Incomplete Revascularization Linked With Increased MACE in Subsequent Noncardiac Surgery

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Precision PCI

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

PCI for STEMI: Fix the Culprit Lesion, or Fix All of the Lesions

TRANSFORM-OCT: 生物可吸收和耐久聚合物 DES 早期和晚期愈合率类似

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

TRANSFORM-OCT: Similar Curación Precoz y Tardía con SLF Bioreabsorbibles y de Polímero Duradero

硬 CTO 斑块的新软化方法可以降低手术难度

Un Nuevo Método para Ablandar la Placa Dura de OTC podría Facilitar las Dificultades de la Intervención

Novel Method of Softening Hard CTO Plaque May Ease Procedural Difficulties

COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events

No-Contrast PCI: A Strategy Based on Intravascular Imaging and Physiology to Avoid Contrast-Induced Nephropathy

Highlights (and my Interpretations) From: ILUMIEN III: OPTIMIZE PCI and COLOR

Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Should the Sequence Be: FFR-PCI-OCT? FFR-PCI-IVUS? Just FFR or just IVUS/OCT? And When Is Angiography Enough?

Imaging Evaluation During PCI: Prediagnostic Value and Post Optimization

Outcome-Derived FFR Threshold for Revascularization: Data From the IRIS FFR Registry (N=7,013)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content